Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lynn Tetrault Insider Profile
4 Followers
Lynn Tetrault, Director at NeoGenomics, holds 50.06K shares in NeoGenomics (Ticker: NEO), holds ― shares in Rhythm Pharmaceuticals (Ticker: RYTM), holds ― shares in ACELYRIN, INC. (Ticker: SLRN). Most recently, Lynn Tetrault Sold ― shares of NeoGenomics on Mar 06, 2024 for an estimated value of 97.55K.
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
-0.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lynn Tetrault holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lynn Tetrault
Lynn Tetrault's Trading History
NeoGenomics
Mar 06, 2024
Director
Informative Sell
97.55K
$707.88K
Rhythm Pharmaceuticals
―
Director
―
―
ACELYRIN, INC.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Lynn Tetrault's performance on stock
You May Also Like
Lynn Tetrault insider profile FAQ
What is the percentage of profitable transactions made by Lynn Tetrault?
The percentage of profitable transactions made by Lynn Tetrault is 57%.
What is the average return per transaction made by Lynn Tetrault?
The average return per transaction made by Lynn Tetrault is -0.50%.
What stocks does Lynn Tetrault hold?
Lynn Tetrault holds: NEO, RYTM, SLRN stocks.
What was Lynn Tetrault’s latest transaction?
Lynn Tetrault latest transaction was an Informative Sell of $97.55K.
What was Lynn Tetrault's most profitable transaction?
Lynn Tetrault’s most profitable transaction was an Informative Buy of NEO stock on May 20, 2022. The return on the trade was 103.50%.
What is Lynn Tetrault's role in NeoGenomics?
Lynn Tetrault's role in NeoGenomics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.